img

Global Antithrombotic Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Antithrombotic Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

AAntithrombotic Treatment (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
Antithrombotic Treatment report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antithrombotic Treatment market is projected to reach US$ 45650 million in 2033, increasing from US$ 29850 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2033. Demand from Hospital and Drugs Stores are the major drivers for the industry.
The antithrombotic treatment market is driven by the increasing prevalence of cardiovascular diseases and the rising aging population, which are significant risk factors for thrombotic disorders. Antithrombotic therapies, including antiplatelet and anticoagulant drugs, play a crucial role in preventing and treating thrombotic events, such as heart attacks and strokes. The growing adoption of these treatments for various thrombotic indications, along with advancements in drug development and personalized medicine, further propel market growth. However, challenges include balancing the risk of bleeding complications with the benefits of preventing thrombotic events, ensuring optimal dosing and adherence to treatment regimens, and addressing the cost burden of long-term therapy. Overcoming these challenges through continuous research, improved patient education, and collaboration between healthcare providers and pharmaceutical companies will be crucial for the sustained growth of the antithrombotic treatment market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Antithrombotic Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


AbbVie
AstraZeneca
Bayer
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Co.
Daiichi Sankyo Co. Ltd.
Eli Lilly and Co.
Roche
GSK
Hikma Pharmaceuticals Plc
Johnson and Johnson Services Inc.
Merck and Co. Inc.
Novartis AG
Otsuka Pharmaceutical Co. Ltd.
Pfizer Inc.
Segment by Type
NOACs
Heparin
Warfarin
Others

Segment by Application


Hospital
Drugs Stores
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antithrombotic Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Antithrombotic Treatment introduction, etc. Antithrombotic Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Antithrombotic Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Antithrombotic Treatment
1.1 Antithrombotic Treatment Market Overview
1.1.1 Antithrombotic Treatment Product Scope
1.1.2 Antithrombotic Treatment Market Status and Outlook
1.2 Global Antithrombotic Treatment Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Antithrombotic Treatment Market Size by Region (2018-2033)
1.4 Global Antithrombotic Treatment Historic Market Size by Region (2018-2023)
1.5 Global Antithrombotic Treatment Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Antithrombotic Treatment Market Size (2018-2033)
1.6.1 North America Antithrombotic Treatment Market Size (2018-2033)
1.6.2 Europe Antithrombotic Treatment Market Size (2018-2033)
1.6.3 Asia-Pacific Antithrombotic Treatment Market Size (2018-2033)
1.6.4 Latin America Antithrombotic Treatment Market Size (2018-2033)
1.6.5 Middle East & Africa Antithrombotic Treatment Market Size (2018-2033)
2 Antithrombotic Treatment Market by Type
2.1 Introduction
2.1.1 NOACs
2.1.2 Heparin
2.1.3 Warfarin
2.1.4 Others
2.2 Global Antithrombotic Treatment Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Antithrombotic Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Antithrombotic Treatment Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Antithrombotic Treatment Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Antithrombotic Treatment Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Antithrombotic Treatment Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Antithrombotic Treatment Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Antithrombotic Treatment Revenue Breakdown by Type (2018-2033)
3 Antithrombotic Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Drugs Stores
3.1.3 Other
3.2 Global Antithrombotic Treatment Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Antithrombotic Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Antithrombotic Treatment Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Antithrombotic Treatment Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Antithrombotic Treatment Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Antithrombotic Treatment Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Antithrombotic Treatment Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Antithrombotic Treatment Revenue Breakdown by Application (2018-2033)
4 Antithrombotic Treatment Competition Analysis by Players
4.1 Global Antithrombotic Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antithrombotic Treatment as of 2022)
4.3 Date of Key Players Enter into Antithrombotic Treatment Market
4.4 Global Top Players Antithrombotic Treatment Headquarters and Area Served
4.5 Key Players Antithrombotic Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Antithrombotic Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Antithrombotic Treatment Products, Services and Solutions
5.1.4 AbbVie Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Antithrombotic Treatment Products, Services and Solutions
5.2.4 AstraZeneca Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Antithrombotic Treatment Products, Services and Solutions
5.3.4 Bayer Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Boehringer Ingelheim International GmbH Recent Developments
5.4 Boehringer Ingelheim International GmbH
5.4.1 Boehringer Ingelheim International GmbH Profile
5.4.2 Boehringer Ingelheim International GmbH Main Business
5.4.3 Boehringer Ingelheim International GmbH Antithrombotic Treatment Products, Services and Solutions
5.4.4 Boehringer Ingelheim International GmbH Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Boehringer Ingelheim International GmbH Recent Developments
5.5 Bristol Myers Squibb Co.
5.5.1 Bristol Myers Squibb Co. Profile
5.5.2 Bristol Myers Squibb Co. Main Business
5.5.3 Bristol Myers Squibb Co. Antithrombotic Treatment Products, Services and Solutions
5.5.4 Bristol Myers Squibb Co. Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Bristol Myers Squibb Co. Recent Developments
5.6 Daiichi Sankyo Co. Ltd.
5.6.1 Daiichi Sankyo Co. Ltd. Profile
5.6.2 Daiichi Sankyo Co. Ltd. Main Business
5.6.3 Daiichi Sankyo Co. Ltd. Antithrombotic Treatment Products, Services and Solutions
5.6.4 Daiichi Sankyo Co. Ltd. Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Daiichi Sankyo Co. Ltd. Recent Developments
5.7 Eli Lilly and Co.
5.7.1 Eli Lilly and Co. Profile
5.7.2 Eli Lilly and Co. Main Business
5.7.3 Eli Lilly and Co. Antithrombotic Treatment Products, Services and Solutions
5.7.4 Eli Lilly and Co. Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Eli Lilly and Co. Recent Developments
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business
5.8.3 Roche Antithrombotic Treatment Products, Services and Solutions
5.8.4 Roche Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Recent Developments
5.9 GSK
5.9.1 GSK Profile
5.9.2 GSK Main Business
5.9.3 GSK Antithrombotic Treatment Products, Services and Solutions
5.9.4 GSK Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 GSK Recent Developments
5.10 Hikma Pharmaceuticals Plc
5.10.1 Hikma Pharmaceuticals Plc Profile
5.10.2 Hikma Pharmaceuticals Plc Main Business
5.10.3 Hikma Pharmaceuticals Plc Antithrombotic Treatment Products, Services and Solutions
5.10.4 Hikma Pharmaceuticals Plc Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Hikma Pharmaceuticals Plc Recent Developments
5.11 Johnson and Johnson Services Inc.
5.11.1 Johnson and Johnson Services Inc. Profile
5.11.2 Johnson and Johnson Services Inc. Main Business
5.11.3 Johnson and Johnson Services Inc. Antithrombotic Treatment Products, Services and Solutions
5.11.4 Johnson and Johnson Services Inc. Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Johnson and Johnson Services Inc. Recent Developments
5.12 Merck and Co. Inc.
5.12.1 Merck and Co. Inc. Profile
5.12.2 Merck and Co. Inc. Main Business
5.12.3 Merck and Co. Inc. Antithrombotic Treatment Products, Services and Solutions
5.12.4 Merck and Co. Inc. Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Merck and Co. Inc. Recent Developments
5.13 Novartis AG
5.13.1 Novartis AG Profile
5.13.2 Novartis AG Main Business
5.13.3 Novartis AG Antithrombotic Treatment Products, Services and Solutions
5.13.4 Novartis AG Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Novartis AG Recent Developments
5.14 Otsuka Pharmaceutical Co. Ltd.
5.14.1 Otsuka Pharmaceutical Co. Ltd. Profile
5.14.2 Otsuka Pharmaceutical Co. Ltd. Main Business
5.14.3 Otsuka Pharmaceutical Co. Ltd. Antithrombotic Treatment Products, Services and Solutions
5.14.4 Otsuka Pharmaceutical Co. Ltd. Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Otsuka Pharmaceutical Co. Ltd. Recent Developments
5.15 Pfizer Inc.
5.15.1 Pfizer Inc. Profile
5.15.2 Pfizer Inc. Main Business
5.15.3 Pfizer Inc. Antithrombotic Treatment Products, Services and Solutions
5.15.4 Pfizer Inc. Antithrombotic Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Pfizer Inc. Recent Developments
6 North America
6.1 North America Antithrombotic Treatment Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Antithrombotic Treatment Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antithrombotic Treatment Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antithrombotic Treatment Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antithrombotic Treatment Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antithrombotic Treatment Market Dynamics
11.1 Antithrombotic Treatment Industry Trends
11.2 Antithrombotic Treatment Market Drivers
11.3 Antithrombotic Treatment Market Challenges
11.4 Antithrombotic Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Antithrombotic Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Antithrombotic Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Antithrombotic Treatment Market Size Share by Region (2018-2023)
Table 4. Global Antithrombotic Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Antithrombotic Treatment Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Antithrombotic Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Antithrombotic Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Antithrombotic Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Antithrombotic Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Antithrombotic Treatment Revenue Market Share by Type (2024-2033)
Table 11. North America Antithrombotic Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Antithrombotic Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Antithrombotic Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Antithrombotic Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Antithrombotic Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Antithrombotic Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Antithrombotic Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Antithrombotic Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Antithrombotic Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Antithrombotic Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Antithrombotic Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Antithrombotic Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Antithrombotic Treatment Revenue Market Share by Application (2018-2023)
Table 24. Global Antithrombotic Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Antithrombotic Treatment Revenue Market Share by Application (2024-2033)
Table 26. North America Antithrombotic Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Antithrombotic Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Antithrombotic Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Antithrombotic Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Antithrombotic Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Antithrombotic Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Antithrombotic Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Antithrombotic Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Antithrombotic Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Antithrombotic Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Antithrombotic Treatment Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Antithrombotic Treatment Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antithrombotic Treatment as of 2022)
Table 39. Date of Key Players Enter into Antithrombotic Treatment Market
Table 40. Global Antithrombotic Treatment Key Players Headquarters and Area Served
Table 41. Antithrombotic Treatment Product Solution and Service
Table 42. Global Antithrombotic Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. AbbVie Basic Information List
Table 45. AbbVie Description and Business Overview
Table 46. AbbVie Antithrombotic Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Antithrombotic Treatment Business of AbbVie (2018-2023)
Table 48. AbbVie Recent Developments
Table 49. AstraZeneca Basic Information List
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Antithrombotic Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Antithrombotic Treatment Business of AstraZeneca (2018-2023)
Table 53. AstraZeneca Recent Developments
Table 54. Bayer Basic Information List
Table 55. Bayer Description and Business Overview
Table 56. Bayer Antithrombotic Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Antithrombotic Treatment Business of Bayer (2018-2023)
Table 58. Bayer Recent Developments
Table 59. Boehringer Ingelheim International GmbH Basic Information List
Table 60. Boehringer Ingelheim International GmbH Description and Business Overview
Table 61. Boehringer Ingelheim International GmbH Antithrombotic Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Antithrombotic Treatment Business of Boehringer Ingelheim International GmbH (2018-2023)
Table 63. Boehringer Ingelheim International GmbH Recent Developments
Table 64. Bristol Myers Squibb Co. Basic Information List
Table 65. Bristol Myers Squibb Co. Description and Business Overview
Table 66. Bristol Myers Squibb Co. Antithrombotic Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Antithrombotic Treatment Business of Bristol Myers Squibb Co. (2018-2023)
Table 68. Bristol Myers Squibb Co. Recent Developments
Table 69. Daiichi Sankyo Co. Ltd. Basic Information List
Table 70. Daiichi Sankyo Co. Ltd. Description and Business Overview
Table 71. Daiichi Sankyo Co. Ltd. Antithrombotic Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Antithrombotic Treatment Business of Daiichi Sankyo Co. Ltd. (2018-2023)
Table 73. Daiichi Sankyo Co. Ltd. Recent Developments
Table 74. Eli Lilly and Co. Basic Information List
Table 75. Eli Lilly and Co. Description and Business Overview
Table 76. Eli Lilly and Co. Antithrombotic Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Antithrombotic Treatment Business of Eli Lilly and Co. (2018-2023)
Table 78. Eli Lilly and Co. Recent Developments
Table 79. Roche Basic Information List
Table 80. Roche Description and Business Overview
Table 81. Roche Antithrombotic Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Antithrombotic Treatment Business of Roche (2018-2023)
Table 83. Roche Recent Developments
Table 84. GSK Basic Information List
Table 85. GSK Description and Business Overview
Table 86. GSK Antithrombotic Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Antithrombotic Treatment Business of GSK (2018-2023)
Table 88. GSK Recent Developments
Table 89. Hikma Pharmaceuticals Plc Basic Information List
Table 90. Hikma Pharmaceuticals Plc Description and Business Overview
Table 91. Hikma Pharmaceuticals Plc Antithrombotic Treatment Products, Services and Solutions
Table 92. Revenue (US$ Million) in Antithrombotic Treatment Business of Hikma Pharmaceuticals Plc (2018-2023)
Table 93. Hikma Pharmaceuticals Plc Recent Developments
Table 94. Johnson and Johnson Services Inc. Basic Information List
Table 95. Johnson and Johnson Services Inc. Description and Business Overview
Table 96. Johnson and Johnson Services Inc. Antithrombotic Treatment Products, Services and Solutions
Table 97. Revenue (US$ Million) in Antithrombotic Treatment Business of Johnson and Johnson Services Inc. (2018-2023)
Table 98. Johnson and Johnson Services Inc. Recent Developments
Table 99. Merck and Co. Inc. Basic Information List
Table 100. Merck and Co. Inc. Description and Business Overview
Table 101. Merck and Co. Inc. Antithrombotic Treatment Products, Services and Solutions
Table 102. Revenue (US$ Million) in Antithrombotic Treatment Business of Merck and Co. Inc. (2018-2023)
Table 103. Merck and Co. Inc. Recent Developments
Table 104. Novartis AG Basic Information List
Table 105. Novartis AG Description and Business Overview
Table 106. Novartis AG Antithrombotic Treatment Products, Services and Solutions
Table 107. Revenue (US$ Million) in Antithrombotic Treatment Business of Novartis AG (2018-2023)
Table 108. Novartis AG Recent Developments
Table 109. Otsuka Pharmaceutical Co. Ltd. Basic Information List
Table 110. Otsuka Pharmaceutical Co. Ltd. Description and Business Overview
Table 111. Otsuka Pharmaceutical Co. Ltd. Antithrombotic Treatment Products, Services and Solutions
Table 112. Revenue (US$ Million) in Antithrombotic Treatment Business of Otsuka Pharmaceutical Co. Ltd. (2018-2023)
Table 113. Otsuka Pharmaceutical Co. Ltd. Recent Developments
Table 114. Pfizer Inc. Basic Information List
Table 115. Pfizer Inc. Description and Business Overview
Table 116. Pfizer Inc. Antithrombotic Treatment Products, Services and Solutions
Table 117. Revenue (US$ Million) in Antithrombotic Treatment Business of Pfizer Inc. (2018-2023)
Table 118. Pfizer Inc. Recent Developments
Table 119. North America Antithrombotic Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 120. North America Antithrombotic Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 121. Europe Antithrombotic Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 122. Europe Antithrombotic Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 123. Asia-Pacific Antithrombotic Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 124. Asia-Pacific Antithrombotic Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 125. Asia-Pacific Antithrombotic Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 126. Asia-Pacific Antithrombotic Treatment Market Share by Region (2018-2023)
Table 127. Asia-Pacific Antithrombotic Treatment Market Share by Region (2024-2033)
Table 128. Latin America Antithrombotic Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 129. Latin America Antithrombotic Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 130. Latin America Antithrombotic Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 131. Middle East & Africa Antithrombotic Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 132. Middle East & Africa Antithrombotic Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 133. Middle East & Africa Antithrombotic Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 134. Antithrombotic Treatment Market Trends
Table 135. Antithrombotic Treatment Market Drivers
Table 136. Antithrombotic Treatment Market Challenges
Table 137. Antithrombotic Treatment Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antithrombotic Treatment Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Antithrombotic Treatment Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Antithrombotic Treatment Market Share by Regions: 2022 VS 2033
Figure 4. Global Antithrombotic Treatment Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Antithrombotic Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Antithrombotic Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Antithrombotic Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Antithrombotic Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Antithrombotic Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of NOACs
Figure 11. Global NOACs Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Heparin
Figure 13. Global Heparin Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Warfarin
Figure 15. Global Warfarin Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Global Antithrombotic Treatment Market Size Share by Type: 2022 & 2033
Figure 19. North America Antithrombotic Treatment Revenue Market Share by Type (2018-2033)
Figure 20. Europe Antithrombotic Treatment Revenue Market Share by Type (2018-2033)
Figure 21. Asia-Pacific Antithrombotic Treatment Revenue Market Share by Type (2018-2033)
Figure 22. Latin America Antithrombotic Treatment Revenue Market Share by Type (2018-2033)
Figure 23. Middle East and Africa Antithrombotic Treatment Revenue Market Share by Type (2018-2033)
Figure 24. Hospital Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Drugs Stores Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Global Antithrombotic Treatment Market Size Share by Application: 2022 & 2033
Figure 28. North America Antithrombotic Treatment Revenue Market Share by Application (2018-2033)
Figure 29. Europe Antithrombotic Treatment Revenue Market Share by Application (2018-2033)
Figure 30. Asia-Pacific Antithrombotic Treatment Revenue Market Share by Application (2018-2033)
Figure 31. Latin America Antithrombotic Treatment Revenue Market Share by Application (2018-2033)
Figure 32. Middle East and Africa Antithrombotic Treatment Revenue Market Share by Application (2018-2033)
Figure 33. Antithrombotic Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Antithrombotic Treatment Market Share in 2022
Figure 35. North America Antithrombotic Treatment Market Share by Country (2018-2033)
Figure 36. U.S. Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 37. Canada Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 38. Germany Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 39. France Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 40. U.K. Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 41. Italy Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 42. Russia Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 43. Nordic Countries Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 44. Asia-Pacific Antithrombotic Treatment Market Share by Region (2018-2033)
Figure 45. China Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 46. Japan Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 47. South Korea Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 49. India Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 50. Australia Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 51. Latin America Antithrombotic Treatment Market Share by Country (2018-2033)
Figure 52. Mexico Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 53. Brazil Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 54. Middle East & Africa Antithrombotic Treatment Market Share by Country (2018-2033)
Figure 55. Turkey Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 57. UAE Antithrombotic Treatment Market Size (2018-2033) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report